Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2024 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory-developed tests; H.R. 3791, the Improving DATA in Public Health Act, and H.R. 3742, a bill to direct a GAO study to evaluate the Federal Governments collection and sharing of public health data to respond to public health emergencies, provisions relating to demographic data reporting obligations for laboratories; H.R. 3795, the Diagnostic Testing Preparedness Plan Act, and H.R. 3840, the Ensuring Sufficient Supply of Testing Act, provisions relating to laboratory testing capabilities in connection with reauthorization of the Pandemics and All-Hazards Preparedness Act; H.R. 3248, the Diagnostic Lab Testing Transparency Act, and Section 105 of H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act, provisions relating to publication of rates for laboratory services; The Patent Eligibility Restoration Act of 2023, provisions relating to patent subject matter eligibility; The American Data Privacy and Protection Act (ADPPA), provisions relating to data privacy; Federal policy related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI); Federal policy related to oversight of artificial intelligence; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS
531 South Spring Street, Burlington, NC, 27215, US
KATHERINE PREGEL DONALD HORTON